Anika Therapeutics ANIK
NASDAQ ANIK
$21.38 +0.12 (+0.56%)
As of: Aug 20, 2026 · 3:59 PM EDT

Anika Therapeutics (ANIK) Amortizatization of Intangibles (2019)

Anika Therapeutics (ANIK) posted quarterly Amortizatization of Intangibles of $294000.0 for Q2 2019, down 1.01% quarter-over-quarter from $297000.0 in Q1 2019.

Anika Therapeutics (ANIK) Amortizatization of Intangibles (2019) Analysis & Trends

Anika Therapeutics (ANIK) has reported Amortizatization of Intangibles for 1 consecutive years, with $294000.0 the latest figure, recorded in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Anika Therapeutics 284.33 Mn 245.92 Mn 21.24 Mn 465,000.00

Historic Data

Download Data
DateValue
Jun 30, 2019 294,000.00
Jun 30, 2019 294,000.00
Mar 31, 2019 297,000.00
Mar 31, 2019 297,000.00